Impact of surfactant protein D, interleukin-5, and eosinophilia on cryptococcosis

Infection and Immunity

Volumn 82, Issue 2, 2014, Pages 683-693

  Holmer, Stephanie M ^a   Evans, Kathy S ^a   Asfaw, Yohannes G ^a   Saini, Divey ^a   Schell, Wiley A ^a   Ledford, Julie G ^a   Frothingham, Richard ^a   Wright, Jo Rae ^a   Sempowski, Gregory D ^a   Perfect, John R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; SURFACTANT PROTEIN D; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DISEASE PREDISPOSITION; EOSINOPHIL; FEMALE; FUNGAL STRAIN; GENE OVEREXPRESSION; HISTOPATHOLOGY; HOST SUSCEPTIBILITY; IMMUNOPHENOTYPING; INFECTION SENSITIVITY; INFLAMMATORY CELL; INNATE IMMUNITY; LOEFFLER PNEUMONIA; LUNG FUNCTION; LUNG LAVAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DISEASE MODELS, ANIMAL; EOSINOPHILIA; FEMALE; INTERLEUKIN-5; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D;

EID: 84893046298     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00855-13     Document Type: Article

References (49)

1. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. 2009. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 23:525-530. http: //dx.doi.org/10.1097/QAD.0b013e328322ffac.
2. Jain AV, Zhang Y, Fields WB, McNamara DA, Choe MY, Chen Gh Erb-Downward J, Osterholzer JJ, Toews GB, Huffnagle GB, Olszewski MA. 2009. Th2 but Not Th1 immune bias results in altered lung functions in a murine model of pulmonary Cryptococcus neoformans Infection. Infect. Immun. 77:5389-5399. http://dx.doi.org/10.1128/IAI.00809-09.
3. Muller U, Stenzel W, Kohler G, Werner C, Polte T, Hansen G, Schutze N, Straubinger RK, Blessing M, McKenzie AN, Brombacher F, Alber G. 2007. IL-13 induces disease-promoting type 2 cytokines, alternatively activated macrophages and allergic inflammation during pulmonary infection of mice with Cryptococcus neoformans. J. Immunol. 179:5367-5377.
4. Hardison SE, Ravi S, Wozniak KL, Young ML, Olszewski MA, Wormley FL, Jr. 2010. Pulmonary infection with an interferon-gamma-producing Cryptococcus neoformans strain results in classical macrophage activation and protection. Am. J. Pathol. 176:774-785. http://dx.doi.org/10.2353 /ajpath.2010.090634.
5. Chen Gh McNamara DA, Hernandez Y, Huffnagle GB, Toews GB, Olszewski MA. 2008. Inheritance of immune polarization patterns is linked to resistance versus susceptibility to Cryptococcus neoformans in a mouse model. Infect. Immun. 76:2379-2391. http://dx.doi.org/10.1128 /IAI.01143-07.
6. Zhang Y, Wang F, Tompkins KC, McNamara A, Jain AV, Moore BB, Toews GB, Huffnagle GB, Olszewski MA. 2009. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am. J. Pathol. 175:2489-2500. http://dx.doi.org/10.2353/ajpath.2009.090530.
7. Wozniak KL, Ravi S, Macias S, Young ML, Olszewski MA, Steele C, Wormley FL. 2009. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS One 4:e6854. http://dx.doi.org/10.1371 /journal.pone.0006854.
8. Huffnagle GB, Boyd MB, Street NE, Lipscomb MF. 1998. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). J. Immunol. 160:2393-2400.
9. Wiesner DL, Boulware DR. 2011. Cryptococcus-related immune reconstitution inflammatory syndrome (IRIS): pathogenesis and its clinical implications. Curr. Fungal Infect. Rep. 5:252-261. http://dx.doi.org/10.1007 /s12281-011-0064-8.
10. da Cunha Colombo ER, Mora DJ, Silva-Vergara ML. 2011. Immune reconstitution inflammatory syndrome (IRIS) associated with Cryptococcus neoformans infection in AIDS patients. Mycoses 54:e178 -182. http: //dx.doi.org/10.1111/j.1439-0507.2010.01870.x.
11. Skiest DJ, Hester LJ, Hardy RD. 2005. Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature. J. Infect. 51:e289 -297. http://dx.doi.org/10.1016 /j.jinf.2005.02.031.
12. Crouch EC. 1998. Collectins and pulmonary host defense. Am. J. Respir. Cell Mol. Biol. 19:177-201. http://dx.doi.org/10.1165/ajrcmb.19.2.140.
13. Geunes-Boyer S, Beers MF, Perfect JR, Heitman J, Wright JR. 2012. Surfactant protein D facilitates Cryptococcus neoformans infection. Infect. Immun. 80:2444-2453. http://dx.doi.org/10.1128/IAI.05613-11.
14. Geunes-Boyer S, Oliver TN, Janbon G, Lodge JK, Heitman J, Perfect JR, Wright JR. 2009. Surfactant proteinDincreases phagocytosis of hypocapsular Cryptococcus neoformans by murine macrophages and enhances fungal survival. Infect. Immun. 77:2783-2794. http://dx.doi.org/10.1128/IAI .00088-09.
15. Korfhagen TR, Sheftelyevich V, Burhans MS, Bruno MD, Ross GF, Wert SE, Stahlman MT, Jobe AH, Ikegami M, Whitsett JA, Fisher JH. 1998. Surfactant protein-D regulates surfactant phospholipid homeostasis in vivo. J. Biol. Chem. 273:28438-28443. http://dx.doi.org/10.1074/jbc .273.43.28438.
16. Lee NA, McGarry MP, Larson KA, Horton MA, Kristensen AB, Lee JJ. 1997. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies. J. Immunol. 158:1332-1344.
17. Morrow CA, Lee IR, Chow EW, Ormerod KL, Goldinger A, Byrnes EJ, III, Nielsen K, Heitman J, Schirra HJ, Fraser JA. 2012. A unique chromosomal rearrangement in the Cryptococcus neoformans var. grubii type strain enhances key phenotypes associated with virulence. mBio 3(2): e00310-11. http://dx.doi.org/10.1128/mBio.00310-11.
18. Saini D, Hopkins GW, Chen CJ, Seay SA, Click EM, Lee S, Hartings JM, Frothingham R. 2011. Sampling port for real-time analysis of bioaerosol in whole body exposure system for animal aerosol model development. J. pharmacological and toxicological methods. 63:143-149. http://dx.doi .org/10.1016/j.vascn.2010.09.002.
19. Steinbach WJ, Benjamin DK, Jr, Trasi SA, Miller JL, Schell WA, Zaas AK, Foster WM, Perfect JR. 2004. Value of an inhalational model of invasive aspergillosis. Med. Mycol. 42:417-425. http://dx.doi.org/10.1080 /13693780410001712034.
20. Awasthi S. 2010. Surfactant protein (SP)-A and SP-D as antimicrobial and immunotherapeutic agents. Recent Pat. Antiinfect. Drug Discov. 5:115- 123. http://dx.doi.org/10.2174/157489110791233559.
21. + monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J. Immunol. 180:2562-2572.
22. Rose S, Misharin A, Perlman H. 2012. A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment. Cytometry 81:343-350. http://dx.doi.org/10.1002/cyto.a.22012.
23. Milam JE, Herring-Palmer AC, Pandrangi R, McDonald RA, Huffnagle GB, Toews GB. 2007. Modulation of the pulmonary type 2 T-cell response to Cryptococcus neoformans by intratracheal delivery of a tumor necrosis factor alpha-expressing adenoviral vector. Infect. Immun. 75: 4951-4958. http://dx.doi.org/10.1128/IAI.00176-07.
24. Kishore U, Madan T, Sarma PU, Singh M, Urban BC, Reid KBM. 2002. Protective roles of pulmonary surfactant proteins, SP-A and SP-D, against lung allergy and infection caused by Aspergillus fumigatus. Immunobiology 205:610-618. http://dx.doi.org/10.1078/0171-2985-00158.
25. Madan T, Kishore U, Singh M, Strong P, Hussain EM, Reid KBM, Sarma PU. 2001. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect. Immun. 69:2728-2731. http://dx.doi.org/10.1128/IAI.69.4.2728-2731.2001.
26. Madan T, Reid KB, Clark H, Singh M, Nayak A, Sarma PU, Hawgood S, Kishore U. 2010. Susceptibility of mice genetically deficient in SP-A or SP-D gene to invasive pulmonary aspergillosis. Mol. Immunol. 47:1923-1930. http://dx.doi.org/10.1016/j.molimm.2010.02.027.
27. Madan T, Reid KB, Singh M, Sarma PU, Kishore U. 2005. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus. J. Immunol. 174:6943-6954.
28. Brandt E, Mingler M, Stevenson M, Wang N, Khuranahershey G, Whitsett J, Rothenberg M. 2008. Surfactant protein D alters allergic lung responses in mice and human subjects. J. Allergy Clin. Immunol. 121: 1140-1147.e1142. http://dx.doi.org/10.1016/j.jaci.2008.02.011.
29. Olszewski MA, Huffnagle GB, Traynor TR, McDonald RA, Cook DN, Toews GB. 2001. Regulatory effects of macrophage inflammatory protein 1α/CCL3 on the development of immunity to Cryptococcus neoformans depend on expression of early inflammatory cytokines. Infect. Immun. 69:6256-6263. http://dx.doi.org/10.1128/IAI.69.10.6256-6263.2001.
30. Olszewski MA, Huffnagle GB, McDonald RA, Lindell DM, Moore BB, Cook DN, Toews GB. 2000. The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection. J. Immunol. 165:6429-6436.
31. Hardison SE, Herrera G, Young ML, Hole CR, Wozniak KL, Wormley FL, Jr. 2012. Protective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation. J. Immunol. 189:4060-4068. http://dx.doi.org/10.4049/jimmunol.1103455.
32. + T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155:4790-4797.
33. Vecchiarelli A, Pietrella D, Bistoni F, Kozel TR, Casadevall A. 2002. Antibody to Cryptococcus neoformans capsular glucuronoxylomannan promotes expression of interleukin-12Rβ2 subunit on human T cells in vitro through effects mediated by antigen-presenting cells. Immunology 106:267-272. http://dx.doi.org/10.1046/j.1365-2567.2002.01419.x.
34. Wormley FL, Perfect JR, Steele C, Cox GM. 2007. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans Strain. Infect. Immun. 75:1453-1462. http://dx.doi.org /10.1128/IAI.00274-06.
35. Salvi S, Semper A, Blomberg A, Holloway J, Jaffar Z, Papi A, Teran L, Polosa R, Kelly F, Sandstrom T, Holgate S, Frew A. 1999. Interleukin-5 production by human airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 20:984-991. http://dx.doi.org/10.1165/ajrcmb.20.5.3463.
36. Wu CA, Peluso JJ, Zhu L, Lingenheld EG, Walker ST, Puddington L. 2010. Bronchial epithelial cells produce IL-5: implications for local immune responses in the airways. Cell Immunol. 264:32-41. http://dx.doi .org/10.1016/j.cellimm.2010.04.008.
37. Ikutani M, Yanagibashi T, Ogasawara M, Tsuneyama K, Yamamoto S, Hattori Y, Kouro T, Itakura A, Nagai Y, Takaki S, Takatsu K. 2012. Identification of innate IL-5-producing cells and their role in lung eosinophil regulation and antitumor immunity. J. Immunol. 188:703-713. http://dx.doi.org/10.4049/jimmunol.1101270.
38. Plaut M, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE. 1989. Mast cell lines produce lymphokines in response to cross-linkage of Fc epsilon RI or to calcium ionophores. Nature 339:64-67. http://dx.doi .org/10.1038/339064a0.
39. Okayama Y, Kobayashi H, Ashman LK, Holgate ST, Church MK, Mori M. 1997. Activation of eosinophils with cytokines produced by lung mast cells. Int. Arch. Allergy Immunol. 114(Suppl 1):75-77. http://dx.doi.org /10.1159/000237724.
40. Diedrich CR, Mattila JT, Flynn JL. 2013. Monocyte-derived IL-5 reduces TNF production by Mycobacterium tuberculosis-specific CD4 T cells during SIV/M tuberculosis coinfection. J. Immunol. 190:6320-6328. http: //dx.doi.org/10.4049/jimmunol.1202043.
41. Feldmesser M, Casadevall A, Kress Y, Spira G, Orlofsky A. 1997. Eosinophil-Cryptococcus neoformans interactions in vivo and in vitro. Infect. Immun. 65:1899-1907.
42. Garro AP, Chiapello LS, Baronetti JL, Masih DT. 2011. Eosinophils elicit proliferation of naive and fungal-specific cells in vivo so enhancing a T helper type 1 cytokine profile in favour of a protective immune response against Cryptococcus neoformans infection. Immunology 134:198-213. http://dx.doi.org/10.1111/j.1365-2567.2011.03479.x.
43. + T cells with a T-helper 1 profile. Immunology 132:174-187. http: //dx.doi.org/10.1111/j.1365-2567.2010.03351.x.
44. Piehler D, Stenzel W, Grahnert A, Held J, Richter L, Kohler G, Richter T, Eschke M, Alber G, Muller U. 2011. Eosinophils contribute to IL-4 production and shape the T-helper cytokine profile and inflammatory response in pulmonary cryptococcosis. Am. J. Pathol. 179:733-744. http: //dx.doi.org/10.1016/j.ajpath.2011.04.025.
45. Linch SN, Kelly AM, Danielson ET, Pero R, Lee JJ, Gold JA. 2009. Mouse eosinophils possess potent antibacterial properties in vivo. Infect. Immun. 77:4976-4982. http://dx.doi.org/10.1128/IAI.00306-09.
46. Erpenbeck VJ, Ziegert M, Cavalet-Blanco D, Martin C, Baelder R, Glaab T, Braun A, Steinhilber W, Luettig B, Uhlig S, Hoymann HG, Krug N, Hohlfeld JM. 2006. Surfactant protein D inhibits early airway response in Aspergillus fumigatus-sensitized mice. Clin. Exp. Allergy 36:930-940. http: //dx.doi.org/10.1111/j.1365-2222.2006.02524.x.
47. Gardai SJ, Xiao YQ, Dickinson M, Nick JA, Voelker DR, Greene KE, Henson PM. 2003. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 115:13-23. http://dx.doi.org/10.1016/S0092-8674(03) 00758-X.
48. Atochina-Vasserman EN, Winkler C, Abramova H, Schaumann F, Krug N, Gow AJ, Beers MF, Hohlfeld JM. 2011. Segmental allergen challenge alters multimeric structure and function of surfactant protein D in humans. Am. J. Respir. Crit. Care Med. 183:856-864. http://dx.doi.org/10 .1164/rccm.201004-0654OC.
49. von Bredow C, Hartl D, Schmid K, Schabaz F, Brack E, Reinhardt D, Griese M. 2006. Surfactant protein D regulates chemotaxis and degranulation of human eosinophils. Clin. Exp. Allergy 36:1566-1574. http://dx .doi.org/10.1111/j.1365-2222.2006.02598.x.